2023 Q3 Form 10-Q Financial Statement

#000095017023039147 Filed on August 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $59.16M $47.98M
YoY Change 15.31% 16.18%
Cost Of Revenue $41.47M $36.11M
YoY Change -5.85% 8.06%
Gross Profit $17.69M $11.87M
YoY Change 143.72% 50.62%
Gross Profit Margin 29.9% 24.74%
Selling, General & Admin $15.83M $23.48M
YoY Change -4.41% -2.67%
% of Gross Profit 89.47% 197.74%
Research & Development $4.380M $4.189M
YoY Change -0.45% -18.44%
% of Gross Profit 24.76% 35.28%
Depreciation & Amortization $1.210M $1.219M
YoY Change -12.51% -22.7%
% of Gross Profit 6.84% 10.27%
Operating Expenses $20.21M $27.67M
YoY Change -3.58% -5.43%
Operating Profit -$2.517M -$15.79M
YoY Change -81.63% -26.11%
Interest Expense -$100.0K $17.00K
YoY Change -122.22% -79.76%
% of Operating Profit
Other Income/Expense, Net -$481.0K -$198.0K
YoY Change -78.67% -82.15%
Pretax Income -$3.105M -$15.97M
YoY Change -81.07% -29.21%
Income Tax $501.0K -$54.00K
% Of Pretax Income
Net Earnings -$3.606M -$15.92M
YoY Change -69.98% -10.69%
Net Earnings / Revenue -6.1% -33.18%
Basic Earnings Per Share -$0.21 -$0.93
Diluted Earnings Per Share -$0.21 -$0.93
COMMON SHARES
Basic Shares Outstanding 17.31M 17.04M
Diluted Shares Outstanding 17.35M 17.16M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.30M $15.79M
YoY Change 17.09% 45.14%
Cash & Equivalents $12.34M $15.79M
Short-Term Investments
Other Short-Term Assets $8.800M $8.927M
YoY Change -28.93% -34.39%
Inventory $76.02M $67.83M
Prepaid Expenses
Receivables $33.82M $20.25M
Other Receivables $0.00 $0.00
Total Short-Term Assets $131.0M $112.8M
YoY Change -23.63% -26.62%
LONG-TERM ASSETS
Property, Plant & Equipment $4.828M $13.21M
YoY Change -11.17% 114.93%
Goodwill $10.69M $10.69M
YoY Change 0.0% 0.0%
Intangibles $1.976M $2.238M
YoY Change -58.77% -56.34%
Long-Term Investments
YoY Change
Other Assets $700.0K $610.0K
YoY Change -96.03% -95.53%
Total Long-Term Assets $25.35M $26.74M
YoY Change -44.68% -38.14%
TOTAL ASSETS
Total Short-Term Assets $131.0M $112.8M
Total Long-Term Assets $25.35M $26.74M
Total Assets $156.3M $139.5M
YoY Change -28.07% -29.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $39.20M $34.04M
YoY Change 31.9% 9.69%
Accrued Expenses $18.60M $18.92M
YoY Change -19.56% -2.76%
Deferred Revenue
YoY Change
Short-Term Debt $13.30M $0.00
YoY Change -70.19% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $74.47M $55.84M
YoY Change -23.59% -15.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.224M $7.443M
YoY Change 3.67% 1.49%
Total Long-Term Liabilities $7.224M $7.443M
YoY Change 3.67% 1.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $74.47M $55.84M
Total Long-Term Liabilities $7.224M $7.443M
Total Liabilities $83.90M $65.48M
YoY Change -22.28% -15.29%
SHAREHOLDERS EQUITY
Retained Earnings -$142.8M -$139.2M
YoY Change 52.98% 71.13%
Common Stock $17.00K $17.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $72.40M $74.06M
YoY Change
Total Liabilities & Shareholders Equity $156.3M $139.5M
YoY Change -28.07% -29.15%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$3.606M -$15.92M
YoY Change -69.98% -10.69%
Depreciation, Depletion And Amortization $1.210M $1.219M
YoY Change -12.51% -22.7%
Cash From Operating Activities -$16.27M -$4.779M
YoY Change -42.46% -82.87%
INVESTING ACTIVITIES
Capital Expenditures $670.0K $365.0K
YoY Change -197.38% -161.24%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$670.0K -$365.0K
YoY Change -2.62% -38.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.62M 259.0K
YoY Change -53.03% -98.37%
NET CHANGE
Cash From Operating Activities -16.27M -4.779M
Cash From Investing Activities -670.0K -365.0K
Cash From Financing Activities 13.62M 259.0K
Net Change In Cash -3.320M -4.885M
YoY Change -9322.22% -61.26%
FREE CASH FLOW
Cash From Operating Activities -$16.27M -$4.779M
Capital Expenditures $670.0K $365.0K
Free Cash Flow -$16.94M -$5.144M
YoY Change -38.59% -81.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001493761
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35465
dei Entity Registrant Name
EntityRegistrantName
TURTLE BEACH CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2767540
dei Entity Address Address Line1
EntityAddressAddressLine1
44 South Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
White Plains
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10601
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
496-8001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17309270
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47982000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41300000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99426000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87962000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
36110000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
33418000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
us-gaap Cost Of Revenue
CostOfRevenue
73415000
us-gaap Cost Of Revenue
CostOfRevenue
66051000
CY2023Q2 us-gaap Gross Profit
GrossProfit
11872000
CY2022Q2 us-gaap Gross Profit
GrossProfit
7882000
us-gaap Gross Profit
GrossProfit
26011000
us-gaap Gross Profit
GrossProfit
21911000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10351000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11587000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19874000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22416000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4189000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5136000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8290000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10388000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13125000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12532000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20132000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18767000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
27665000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
29255000
us-gaap Operating Expenses
OperatingExpenses
48296000
us-gaap Operating Expenses
OperatingExpenses
51571000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15793000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21373000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22285000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29660000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
17000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-84000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-146000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-193000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-198000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1109000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-318000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1828000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15974000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22566000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22749000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31681000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4740000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7379000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17826000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
us-gaap Net Income Loss
NetIncomeLoss
-24302000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19846000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21808000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17156000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16500000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16869000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16348000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17156000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16500000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16869000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16348000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17826000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
us-gaap Net Income Loss
NetIncomeLoss
-24302000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1090000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
410000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1519000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1090000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
410000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1519000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15955000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18916000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22215000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25821000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15787000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11396000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20254000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43336000
CY2023Q2 us-gaap Inventory Net
InventoryNet
67831000
CY2022Q4 us-gaap Inventory Net
InventoryNet
71252000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8927000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9196000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
112799000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
135180000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5691000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6362000
CY2023Q2 us-gaap Goodwill
Goodwill
10686000
CY2022Q4 us-gaap Goodwill
Goodwill
10686000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2238000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2612000
CY2023Q2 us-gaap Other Assets
OtherAssets
8124000
CY2022Q4 us-gaap Other Assets
OtherAssets
8547000
CY2023Q2 us-gaap Assets
Assets
139538000
CY2022Q4 us-gaap Assets
Assets
163387000
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
19053000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
34036000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25433000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
55844000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64332000
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2196000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2076000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7443000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8038000
CY2023Q2 us-gaap Liabilities
Liabilities
65483000
CY2022Q4 us-gaap Liabilities
Liabilities
74446000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17309270
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17309270
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16569173
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16569173
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
17000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
214245000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
206916000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-139223000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116598000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-984000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1394000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
74055000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
88941000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139538000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
163387000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
us-gaap Net Income Loss
NetIncomeLoss
-24302000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1948000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2458000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
513000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
623000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
75000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
94000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6929000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3567000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-209000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7110000
hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
2419000
hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
4992000
us-gaap Inventory Write Down
InventoryWriteDown
-1098000
us-gaap Inventory Write Down
InventoryWriteDown
-1289000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32685000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32152000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5457000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21288000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7452000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9914000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-691000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1055000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-261000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1550000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4928000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-13851000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24210000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41247000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1252000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1207000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1252000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1207000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
99785000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
36209000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
118838000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
20502000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1358000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
538000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
974000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
80000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18749000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16245000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
182000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-634000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4391000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26843000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11396000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37720000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15787000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10877000
us-gaap Interest Paid Net
InterestPaidNet
226000
us-gaap Interest Paid Net
InterestPaidNet
108000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-137000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2539000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
88941000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6705000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
445000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
124000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1959000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
84764000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1234000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4986000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
974000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
74055000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
141369000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6476000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-429000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
361000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1537000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
136362000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17826000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1090000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
177000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2030000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
119653000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: The preparation of accompanying unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements in the period in which such changes occur. Future actual results could differ materially from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2508000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4171000
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
2889000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4159000
CY2023Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2609000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4147000
CY2023Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1596000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
67071000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
70407000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
760000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
845000
CY2023Q2 us-gaap Inventory Net
InventoryNet
67831000
CY2022Q4 us-gaap Inventory Net
InventoryNet
71252000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35022000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33812000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29331000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27450000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5691000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6362000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2527000
CY2023Q2 hear Accrued Freight Current
AccruedFreightCurrent
2027000
CY2022Q4 hear Accrued Freight Current
AccruedFreightCurrent
1746000
CY2023Q2 hear Accrued Expenses Current
AccruedExpensesCurrent
10179000
CY2022Q4 hear Accrued Expenses Current
AccruedExpensesCurrent
8683000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21808000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25433000
CY2023Q2 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1225000
CY2023Q2 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
1349000
CY2023Q2 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
-124000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11810000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9572000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2238000
CY2022Q4 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1375000
CY2022Q4 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
1344000
CY2022Q4 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
31000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11660000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9048000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2612000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
516000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1003000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
425000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
170000
CY2023Q2 hear Finite Lived Intangible Assets Amortization Expense After Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
0
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2114000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
us-gaap Interest Expense Debt
InterestExpenseDebt
200000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
us-gaap Interest Expense Debt
InterestExpenseDebt
200000
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
75000
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
94000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4740000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7379000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.003
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2023Q2 hear Unrecognized Tax Benefits Inclusive Of Interest And Penalties
UnrecognizedTaxBenefitsInclusiveOfInterestAndPenalties
2900000
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4970000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2030000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6929000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3567000
hear Share Based Compensation Expenses Related Payroll
ShareBasedCompensationExpensesRelatedPayroll
4000000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
550000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11000
hear Performance Shares Unearned
PerformanceSharesUnearned
94000
hear Performance Shares Granted
PerformanceSharesGranted
163000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1577545
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.66
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M21D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2465015
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
343007
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11485
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.48
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1223053
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.63
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M8D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4707610
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1222015
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.73
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y5M8D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4699256
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1087615
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M20D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4211217
hear Sharebased Compensation Arrangement By Sharebased Payment Award Forfeiture Period After Ending Employment
SharebasedCompensationArrangementBySharebasedPaymentAwardForfeiturePeriodAfterEndingEmployment
P90D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2400000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
600000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15920000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17826000
us-gaap Net Income Loss
NetIncomeLoss
-22625000
us-gaap Net Income Loss
NetIncomeLoss
-24302000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17156000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16500000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16869000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16348000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17156000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16500000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16869000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16348000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2821000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3168000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2794000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3137000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47982000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41300000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99426000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87962000
CY2020Q2 hear Number Of Shareholders
NumberOfShareholders
8
CY2020Q3 hear Number Of Motions
NumberOfMotions
2
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
616000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
789000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
618000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
856000
CY2023Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
190000
CY2022Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
72000
us-gaap Product Warranty Expense
ProductWarrantyExpense
375000
us-gaap Product Warranty Expense
ProductWarrantyExpense
193000
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
166000
CY2022Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
143000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
353000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
331000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
640000
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
718000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
640000
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
718000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7514000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1092000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7091000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8183000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
us-gaap Operating Lease Payments
OperatingLeasePayments
600000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
647000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1437000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1451000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1361000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1383000
CY2023Q2 hear Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3182000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9461000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1278000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8183000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true

Files In Submission

Name View Source Status
0000950170-23-039147-index-headers.html Edgar Link pending
0000950170-23-039147-index.html Edgar Link pending
0000950170-23-039147.txt Edgar Link pending
0000950170-23-039147-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hear-20230630.htm Edgar Link pending
hear-20230630.xsd Edgar Link pending
hear-ex10_4.htm Edgar Link pending
hear-ex10_5.htm Edgar Link pending
hear-ex10_6.htm Edgar Link pending
hear-ex10_7.htm Edgar Link pending
hear-ex31_1.htm Edgar Link pending
hear-ex31_2.htm Edgar Link pending
hear-ex32_1.htm Edgar Link pending
img252838241_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
hear-20230630_cal.xml Edgar Link unprocessable
hear-20230630_def.xml Edgar Link unprocessable
hear-20230630_lab.xml Edgar Link unprocessable
hear-20230630_pre.xml Edgar Link unprocessable
hear-20230630_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable